Biofrontera Inc. seeks IPO in the USA
July 06 2021 - 4:59PM
Biofrontera AG currently holds 100 % of the shares of the US-based
Biofrontera Inc.
Biofrontera AG had already announced that
opportunities for capital raises were being evaluated including a
potential initial public offering ("IPO") of Biofrontera Inc. in
the United States.
The main objectives of an IPO of Biofrontera
Inc. would be to raise additional capital to fund its growth of
operations, to create a public market for its shares and to
facilitate future access to the capital market.
A registration statement relating to the
securities to be offered in the IPO has been filed with the
Securities and Exchange Commission but has not yet become
effective. These securities may not be sold nor may offers to buy
these securities be accepted prior to the time the registration
statement becomes effective. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy
nor shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
Biofrontera AG, Hemmelrather Weg 201, 51377
LeverkusenISIN: DE0006046113WKN: 604611
Contact: Biofrontera AGTel: +49 (0214) 87 63 2
0, Fax: +49 (0214) 87 63 290Email: ir@biofrontera.com
Forward-Looking Statements: Certain statements
in this press release are forward-looking within the meaning of the
Private Securities Litigation Reform Act of 1995 regarding the
public offering and the intended use of proceeds from the
offering.
These statements may be identified by the use of
forward-looking words such as "anticipate," "believe," "forecast,"
"estimate" and "intend," among others. Such forward-looking
statements are based on the currently held beliefs and assumptions
of the management of Biofrontera AG, which are expressed in good
faith and, in their opinion, reasonable. Forward-looking statements
involve known and unknown risks, uncertainties and other factors,
which may cause the actual results, financial condition,
performance, or achievements of the Company, or industry results,
to differ materially from the results, financial condition,
performance or achievements expressed or implied by such
forward-looking statements. These risks, uncertainties and other
factors are set forth in the annual report on Form 20-F filed with
the SEC, including Item 3.D. "Key Information - Risk Factors," and
in future reports filed with the SEC. Given these risks,
uncertainties and other factors, prospective investors are
cautioned not to place undue reliance on these forward-looking
statements. The Company does not undertake an obligation to update
or revise any forward-looking statement.
Biofrontera (NASDAQ:BFRA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biofrontera (NASDAQ:BFRA)
Historical Stock Chart
From Jul 2023 to Jul 2024